Jessie Sun
Senior Director - Drug Substance, Manufacturing Science & Technology Ultragenyx Pharmaceutical Inc.
Seminars
Thursday 25th February 2027
Panel Discussion: Establishing Risk-Based Process Development Decision Frameworks to Accelerate Clinical Progression
11:00 am
- Defining fit-for-purpose process performance criteria to accelerate clinical progression while maintaining robust, reliable and reproducible viral vector manufacturing
- Assessing technology adoption and supplier diversification strategies to reduce operational risk while maximizing value from established manufacturing platforms
- Balancing process optimization efforts against program timelines, manufacturing costs and patient demand to enable data-driven development decisions
